日常与终生歧视经历与接受阿尔茨海默病预测性检测意愿的关联
研究基于2010年和2012年健康与退休研究,纳入1499名受访者,分析日常歧视(6项)和终生歧视(7项)与接受免费阿尔茨海默病预测性检测意愿的关联。80%受访者表示有兴趣;在黑人(RD日常歧视=-0.026,95%CI -0.081至0.029)和拉丁裔(RD日常歧视=-0.023,95%CI -0.082至0.039)参与者中,歧视经历与检测意愿无显著关联。黑人和拉丁裔个体仍对AD检测表达兴趣,但其在AD研究中代表性不足。
要点
- 80%受访者对免费阿尔茨海默病预测性检测表示兴趣。
- 黑人(RD日常歧视=-0.026,95%CI -0.081至0.029)和拉丁裔(RD日常歧视=-0.023,95%CI -0.082至0.039)参与者中,歧视与检测意愿无显著关联。
- 有兴趣者更年轻(66岁 vs 70岁),黑人或拉丁裔比例更高(黑人20% vs 15%;拉丁裔14% vs 8%)。
核心结论
- 尽管存在历史和当代歧视经历,黑人和拉丁裔个体仍对阿尔茨海默病预测性检测表达兴趣。
- 黑人和拉丁裔个体在阿尔茨海默病研究(包括检测研究)中仍代表性不足。
- 对痴呆风险个性化信息的兴趣可能是增强其参与研究和临床试验的途径。
研究设计与样本
- 研究利用2010年和2012年健康与退休研究双年调查波次,随机选取受访者完成关于接受免费阿尔茨海默病预测性检测意愿的问题。
- 分析样本共1499名受访者,平均年龄67岁(SD=10.2),57.4%为女性,65.7%为白人。
- 暴露变量为日常歧视(6项)和终生歧视(7项),均转换为二分类变量。
- 采用逻辑回归模型预测检测意愿,并控制每个歧视测量倾向评分的十分位数,将比值比重新表达为风险差(RD)。
主要发现
- 80%的受访者表示对阿尔茨海默病预测性检测有兴趣。
- 54.7%的参与者在至少一个领域经历过日常歧视;24.1%在至少一个领域经历过重大终生歧视。
- 有兴趣接受预测性检测者更年轻(66岁 vs 70岁),且黑人或拉丁裔比例更高(黑人20% vs 15%;拉丁裔14% vs 8%)。
- 黑人参与者中,检测意愿与日常歧视(RD=-0.026;95%CI -0.081至0.029)或终生歧视(RD=-0.012;95%CI -0.085至0.063)无显著关联。
- 拉丁裔参与者中,检测意愿与日常歧视(RD=-0.023;95%CI -0.082至0.039)或终生歧视(RD=-0.011;95%CI -0.087至0.064)无显著关联。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Rapid developments in Alzheimer disease (AD) biomarker research suggest that predictive testing may become widely available. To ensure equal access to AD predictive testing, it is important to understand factors that affect testing interest. Discrimination may influence attitudes toward AD testing, particularly among racially and ethnically minoritized populations, because of structural racism in health care systems. This study examined whether everyday or lifetime discrimination experiences shape interest in AD predictive testing. METHODS: In the 2010 and 2012 biennial Health and Retirement Study waves, respondents were randomly selected to complete questions on interest in receiving free testing that could determine whether they would develop AD in the future. The exposures were everyday discrimination (6 items) and lifetime discrimination (7 items); both were transformed into a binary variable. Logistic regression models predicting interest in AD testing were controlled for deciles of propensity scores for each discrimination measure. Odds ratios were re-expressed as risk differences (RDs). RESULTS: Our analytic sample included 1,499 respondents. The mean age was 67 (SD = 10.2) years, 57.4% were women, 65.7% were White, and 80% endorsed interest in AD predictive testing. Most of the participants (54.7%) experienced everyday discrimination in at least one domain; 24.1% experienced major lifetime discrimination in at least one domain. Those interested in predictive testing were younger (66 vs 70 years) and more likely to be Black (20% vs 15%) or Latinx (14% vs 8%) than participants uninterested in testing. The probability of wanting an AD test was not associated with discrimination for Black (RD everyday discrimination = -0.026; 95% CI [-0.081 to 0.029]; RD lifetime discrimination = -0.012; 95% CI [-0.085 to 0.063]) or Latinx (RD everyday discrimination = -0.023, 95% CI [-0.082 to 0.039]; RD lifetime discrimination = -0.011; 95% CI [-0.087 to 0.064]) participants. DISCUSSION: Despite historical and contemporary experiences of discrimination, Black and Latinx individuals express interest in AD testing. However, Black and Latinx individuals remain underrepresented in AD research, including research on AD testing. Interest in personalized information about dementia risk may be a pathway to enhance their inclusion in research and clinical trials.
引用
- Hill-Jarrett TG, Choi M, Buto PT, et al. Associations of Everyday and Lifetime Experiences of Discrimination With Willingness to Undergo Alzheimer Disease Predictive Testing. Neurology. 2024. PMID: 38266219. doi:10.1212/WNL.0000000000208005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。